Insmed, Inc. (INSM)

160.82 +9.71 (+6.43%) USD  |  NASDAQ  |  Feb 19, 16:00
160.45 -0.37 (-0.23%) After-Hours: 17:19
More

Insmed EPS Diluted (TTM) : -6.181 for Sept. 30, 2025

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for INSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. 2.257
Biogen, Inc. 8.806
CorMedix, Inc. 2.053
Merck & Co., Inc. 7.275
Pfizer Inc. 1.355